ViewRay Systems(OTC) VRAYQ

Market Cap$200.00

Since IPO (2015)-100%

5 Year-100%

1 Year+0%

1 Month+0%

$0.00

+0%

+0.00Today

ViewRay Systems last closing stock price
Metric	Price	Date
Last close	USD 0.00	2026-07-27

ViewRay Systems stock price return by period
Period	Price return	Price at period start	Period start date
1 week	+0%	USD 0.00	2026-07-16
1 month	+0%	USD 0.00	2026-06-26
3 month	+0%	USD 0.00	2026-04-24
Year to date	+0%	USD 0.00	2025-12-31
1 year	+0%	USD 0.00	2025-07-25
3 year	-100%	USD 0.02	2023-07-28
5 year	-100%	USD 6.56	2021-07-28
Since inception	-100%	USD 5.00	2015-08-10

ViewRay Systems Financials at a Glance

Market Cap

$200.00

Revenue (TTM)

$105.86M

Net Income (TTM)

-$110.42M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-79.48 (Low)

Dividend

$0.00

Beta (Volatility)

-79.48 (Low)

Price

$0.00

Volume

33,096

Open

$0.00

Price

$0.00

Volume

33,096

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

May 29, 2026

Dividend

$0.00

Beta (Volatility)

-79.48 (Low)

Price

$0.00

Volume

33,096

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

May 29, 2026

VRAYQ News

Page 1

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About ViewRay Systems

ViewRay, Inc. specializes in developing advanced radiation therapy systems that utilize magnetic resonance imaging (MRI) for cancer treatment. The company's flagship product, MRIdian, integrates imaging and treatment delivery, addressing critical concerns in cancer care.

Products and Services

MRIdian: MRI-guided radiation therapy system
Advanced imaging technology for precise treatment
Global distribution to various medical facilities

Growth Outlook

Increasing demand for innovative cancer treatment solutions
Expansion into international markets, including Europe and Asia
Focus on enhancing product features and capabilities

Financial Highlights

Q1 2023 revenue of $22.5 million, down from $34.7 million in Q4 2022
Net income for Q1 2023 was -$30.7 million, reflecting ongoing operational challenges
Cash and cash equivalents of $81.3 million as of March 31, 2023

ViewRay, Inc. operates in the healthcare sector, focusing on innovative solutions for cancer treatment. The company's MRIdian system is designed to improve patient outcomes by providing real-time imaging during radiation therapy. Despite recent financial challenges, including a decline in revenue and net income, ViewRay maintains a strong cash position, which may support future growth initiatives. The company is well-positioned to capitalize on the increasing global demand for advanced cancer treatment technologies.

AI Generated • Jul 2, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

295

CEO

Scott William Drake

Website

www.viewray.com

Headquarters

Oakwood Village, OH 44146, US

VRAYQ Financials

Key Financial Metrics (TTM)

Gross Margin

9.83%

Operating Margin

-104.81%

Net Income Margin

-105.21%

Return on Equity

-85.33%

Return on Capital

-63.52%

Return on Assets

-39.62%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$200.00

Shares Outstanding

183.40M

Volume

33.10K

Avg. Volume

4.31K

Financials (TTM)

Gross Profit

$8.52M

Operating Income

-$109.28M

EBITDA

-$99.06M

Operating Cash Flow

-$112.92M

Capital Expenditure

-$3.86M

Free Cash Flow

-$116.78M

Cash & ST Invst.

$81.29M

Total Debt

$85.13M

ViewRay Systems Performance Analysis

ViewRay Systems annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2021	2021-12-31	USD 70,119,000	N/A
2022	2022-12-31	USD 102,206,000	45.8%

ViewRay Systems sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q2	2022-06-30	17.3%
Q3	2022-09-30	19.6%
Q4	2022-12-31	31.0%
Q1	2023-03-31	-35.0%

ViewRay Systems annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2021	2021-12-31	USD -0.67	N/A
2022	2022-12-31	USD -0.59	-11.2%

ViewRay Systems sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q2	2022-06-30	-7.1%
Q3	2022-09-30	6.7%
Q4	2022-12-31	-7.1%
Q1	2023-03-31	-6.7%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2023YOY CHG

Revenue

$22.53M

+19.4%

Gross Profit

-$1.43M

-1621.3%

Gross Margin

-6.35%

N/A

Market Cap

$200.00

N/A

Market Cap/Employee

$0.68

N/A

Employees

295

N/A

Net Income

-$28.86M

-12.0%

EBITDA

-$25.25M

-7.7%

Quarterly Fundamentals

Name

Q1 2023YOY CHG

Total Cash

$81.29M

-54.9%

Total Debt

$85.13M

+26.4%

Accounts Receivable

$47.53M

+69.7%

Inventory

$42.19M

+61.8%

Long Term Debt

$4.44M

-92.2%

Short Term Debt

$80.69M

+654.9%

Return on Assets

-39.62%

N/A

Return on Invested Capital

-61.28%

N/A

Free Cash Flow

-$54.78M

-63.0%

Operating Cash Flow

-$53.60M

-65.5%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

LOWLFLowell Farms Inc.

LOWLFLowell Farms Inc.$0.00+0.00%

CBGIThe CannaBusiness Group, Inc.

CBGIThe CannaBusiness Group, Inc.$0.00+0.00%

ASFXAmerican Scientific Resources, Incorporated

ASFXAmerican Scientific Resources, Incorporated$0.00+0.00%

CEVECeres Ventures, Inc.

CEVECeres Ventures, Inc.$0.00+0.00%

MDITMedite Cancer Diagnostics, Inc.

MDITMedite Cancer Diagnostics, Inc.$0.00+0.00%

SDCCQSmileDirectClub Inc Class A

SDCCQSmileDirectClub Inc Class A$0.00+0.00%

HSMDHealthcare Solutions Management Group, Inc.

HSMDHealthcare Solutions Management Group, Inc.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SOFISoFi Technologies

SOFISoFi Technologies$15.55-0.07%

INTCIntel

INTCIntel$83.98-0.03%

NVDANvidia

NVDANvidia$192.48-0.02%

FFord Motor Company

FFord Motor Company$15.50+0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$60.07-0.02%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.46+0.05%

NOKNokia

NOKNokia$8.50-0.05%

Questions About VRAYQ

What is the current price of ViewRay Systems?

ViewRay Systems is trading at $0.00 per share.

What is the 52-week range for ViewRay Systems?

Over the past 52 weeks, ViewRay Systems has traded between $0.00 and $0.00.

How much debt does ViewRay Systems have?

As of the most recent reporting period, ViewRay Systems reported total debt of $86.40M.

How much cash does ViewRay Systems have on hand?

ViewRay Systems reported $135.96M in cash and cash equivalents in its most recent financial results.

What is ViewRay Systems’s dividend yield?

ViewRay Systems does not currently have a dividend yield.

ViewRay Systems(OTC) VRAYQ

ViewRay Systems Financials at a Glance

VRAYQ News

Why ViewRay Stock Is Sinking Today

Why ViewRay Crushed the Market on Thursday

Why ViewRay Stock Vaulted Higher Today

Why ViewRay Stock Got Crushed Today

Why ViewRay Stock Dropped Today

Why ViewRay Stock Is Tanking Today

Why Lands' End, Audentes Therapeutics, and ViewRay Jumped Today

Why ViewRay Stock Is Shooting Higher Today

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About ViewRay Systems

VRAYQ Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

ViewRay Systems Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About VRAYQ

What is the current price of ViewRay Systems?

What is the 52-week range for ViewRay Systems?

How much debt does ViewRay Systems have?

How much cash does ViewRay Systems have on hand?

What is ViewRay Systems’s dividend yield?

Premium Investing Services